Cargando…

Efficacy of Tocilizumab Therapy in Different Subtypes of COVID-19 Cytokine Storm Syndrome

Background: Cytokine storm in COVID-19 is heterogenous. There are at least three subtypes: cytokine release syndrome (CRS), macrophage activation syndrome (MAS), and sepsis. Methods: A retrospective study comprising 276 patients with SARS-CoV-2 pneumonia. All patients were tested for ferritin, inter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliynyk, Oleksandr, Barg, Wojciech, Slifirczyk, Anna, Oliynyk, Yanina, Gurianov, Vitaliy, Rorat, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229480/ https://www.ncbi.nlm.nih.gov/pubmed/34205217 http://dx.doi.org/10.3390/v13061067

Ejemplares similares

Lack of Difference in Tocilizumab Efficacy in the Treatment of Severe COVID-19 Caused by Different SARS-CoV-2 Variants
por: Oliynyk, Oleksandr, et al.
Publicado: (2022)

Comparison of the Effect of Unfractionated Heparin and Enoxaparin Sodium at Different Doses on the Course of COVID-19-Associated Coagulopathy
por: Oliynyk, Oleksandr, et al.
Publicado: (2021)

Efficacy of Sildenafil in Patients with Severe COVID-19 and Pulmonary Arterial Hypertension
por: Oliynyk, Oleksandr Valentynovych, et al.
Publicado: (2023)

Oxygen metabolism markers as predictors of mortality in severe COVID-19
por: Oliynyk, Oleksandr V., et al.
Publicado: (2021)

Impact of Alteplase on Mortality in Critically Ill Patients with COVID-19 and Pulmonary Embolism
por: Oliynyk, Oleksandr Valentynovych, et al.
Publicado: (2023)

Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome
por: Sarhan, Neven Mohamed, et al.
Publicado: (2023)

Can tocilizumab calm the cytokine storm of COVID-19?
por: Schulert, Grant S
Publicado: (2020)

Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19
por: Saha, Abinit, et al.
Publicado: (2020)

Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?
por: Antinori, Spinello, et al.
Publicado: (2020)

Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
por: Langer-Gould, Annette, et al.
Publicado: (2020)

Future Preventive Gene Therapy of Polygenic Diseases from a Population Genetics Perspective
por: Oliynyk, Roman Teo
Publicado: (2019)

Quantifying the Potential for Future Gene Therapy to Lower Lifetime Risk of Polygenic Late-Onset Diseases
por: Oliynyk, Roman Teo
Publicado: (2019)

A Neonate With Cytokine Storm Managed With Steroids, Therapeutic Plasma Exchange, and Tocilizumab
por: LiKamWa, Amy, et al.
Publicado: (2023)

2648. Taming the Cytokine Storm: Baricitinib versus Tocilizumab for COVID-19 Hyperinflammation
por: Radziszewski, Skyler, et al.
Publicado: (2023)

Age-related late-onset disease heritability patterns and implications for genome-wide association studies
por: Oliynyk, Roman Teo
Publicado: (2019)

Evaluating the Potential of Younger Cases and Older Controls Cohorts to Improve Discovery Power in Genome-Wide Association Studies of Late-Onset Diseases
por: Oliynyk, Roman Teo
Publicado: (2019)

Human-caused wolf mortality persists for years after discontinuation of hunting
por: Oliynyk, Roman Teo
Publicado: (2023)

Author Correction: Human-caused wolf mortality persists for years after discontinuation of hunting
por: Oliynyk, Roman Teo
Publicado: (2023)

Role of Tocilizumab in the Treatment of COVID-19 Patients with Cytokine Storm: A Case Series
por: Basnet, Ajaya, et al.
Publicado: (2022)

Actoprotective effect of ginseng: improving mental and physical performance
por: Oliynyk, Sergiy, et al.
Publicado: (2013)

The Pharmacology of Actoprotectors: Practical Application for Improvement of Mental and Physical Performance
por: Oliynyk, Sergiy, et al.
Publicado: (2012)

Hypoxia modeling techniques: A review
por: Salyha, Nataliya, et al.
Publicado: (2023)

Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence
por: Pelaia, Corrado, et al.
Publicado: (2021)

Specimen Size Effect on the Tensile Properties of Rolled Steel of Long-Term-Operated Portal Crane
por: Zvirko, Olha, et al.
Publicado: (2023)

CALM BEFORE THE STORM: COVID-19 AND CYTOKINE STORM SYNDROME
por: Chahal, Japjot, et al.
Publicado: (2020)

A Silent Killer: Left Main Coronary Artery Disease in Gastrointestinal Bleed
por: Afify, Hesham, et al.
Publicado: (2021)

Efficient modification and preparation of circular DNA for expression in cell culture
por: Oliynyk, Roman Teo, et al.
Publicado: (2022)

Intravenous anakinra for cytokine storm syndromes
por: Jamilloux, Yvan, et al.
Publicado: (2020)

Successful treatment of acute heart failure in COVID-19-induced cytokine storm with tocilizumab: a case report
por: Chitturi, Kalyan R, et al.
Publicado: (2020)

Cytokine Storm
por: Fajgenbaum, David C., et al.
Publicado: (2020)

Tocilizumab, an IL6-receptor antibody, proved effective as adjuvant therapy for cytokine storm induced by severe infection in patients with hematologic malignancy
por: Wang, Bingjie, et al.
Publicado: (2023)

Cytokine storm syndrome in severe COVID-19
por: Ruscitti, Piero, et al.
Publicado: (2020)

Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care
por: Quartuccio, Luca, et al.
Publicado: (2020)

Automatic online spike sorting with singular value decomposition and fuzzy C-mean clustering
por: Oliynyk, Andriy, et al.
Publicado: (2012)

Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm
por: Guo, Chuang, et al.
Publicado: (2020)

COVID-19: In the Eye of the Cytokine Storm
por: de la Rica, Roberto, et al.
Publicado: (2020)

Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study
por: Ramiro, Sofia, et al.
Publicado: (2020)

The effect of tocilizumab on cytokine release syndrome in COVID-19 patients
por: de Cáceres, Carmen, et al.
Publicado: (2020)

Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19
por: Hassoun, Ali, et al.
Publicado: (2020)

COVID-19: consider cytokine storm syndromes and immunosuppression
por: Mehta, Puja, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9o88802iubv84tgaqaj4d6q0qq